Innate antimicrobial immunity in inflammatory bowel diseases. - Wikidata - wikimedia - TriplyDB

Innate antimicrobial immunity in inflammatory bowel diseases.

Innate antimicrobial immunity in inflammatory bowel diseases.

http://www.wikidata.org/entity/Q37786633

about

Successful treatment of asymptomatic or clinically terminal bovine Mycobacterium avium subspecies paratuberculosis infection (Johne's disease) with the bacterium Dietzia used as a probiotic alone or in combination with dexamethasone: Adaption to chr The implications of oxidative stress and antioxidant therapies in Inflammatory Bowel Disease: Clinical aspects and animal models.Animal models of inflammatory bowel disease: a review.Pathomechanisms of Oxidative Stress in Inflammatory Bowel Disease and Potential Antioxidant Therapies.A Potential 'Curative' Modality for Crohn's Disease---Modeled after Prophylaxis of Bovine Johne's Disease.The JAK2 variant rs10758669 in Crohn's disease: altering the intestinal barrier as one mechanism of action.SHANK3 Regulates Intestinal Barrier Function Through Modulating ZO-1 Expression Through the PKCε-dependent Pathway.Anti-TNF-alpha antibody (infliximab) therapy supports the recovery of eNOS and VEGFR2 protein expression in endothelial cells.

P2860

Q35693684-51BFCE42-8ECC-4AEA-B18D-80966FF15123 Q36606775-72D1F504-6EDE-436A-A093-DCDDC93A35D0 Q38218335-1BAC937A-1EFF-45A2-AB05-B3FF503B05A6 Q39458419-FD437078-E63B-483C-B747-F624ABE0CCE9 Q41905099-CD9B6ED7-8731-4D64-A2BB-C5DB49712FE8 Q46235419-C1FE096E-F24E-4C17-88E0-5213CB5F2D26 Q47803871-B9A1F0E0-DED4-4E5C-AC93-6FF0A67CA2B0 Q54365605-AB0FED20-21C7-42C2-8F92-04122891706E

P2860

Innate antimicrobial immunity in inflammatory bowel diseases.

http://www.wikidata.org/entity/Q37786633

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on September 2010

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Innate antimicrobial immunity in inflammatory bowel diseases.

@en

Innate antimicrobial immunity in inflammatory bowel diseases.

@nl

type

label

Innate antimicrobial immunity in inflammatory bowel diseases.

@en

Innate antimicrobial immunity in inflammatory bowel diseases.

@nl

prefLabel

Innate antimicrobial immunity in inflammatory bowel diseases.

@en

Innate antimicrobial immunity in inflammatory bowel diseases.

@nl

P1433

Q37786633-9D570797-E8E2-4CD0-A1BE-A376D1DFAFE7

P1476

Q37786633-A2B43409-473E-4B41-8559-F439181CAED2

P2093

Q37786633-218211A2-670B-4D86-A5EF-1AA538C74083

Q37786633-3691ED35-DD35-49AB-A4D9-85C549533084

P2860

Q37786633-0155BF33-AC20-42BD-9B49-689B51B96C31

Q37786633-01A59323-C2E7-493B-9CFD-A6F6CE6E7DE7

Q37786633-02D59675-BCC5-45B5-B1A4-16F096D2074E

Q37786633-02E373D2-B494-41F6-BAEE-6D69F8867B50

Q37786633-04C89A1D-AE6A-4DD8-BABD-35893C127098

Q37786633-05685B35-C547-4350-B3FC-E8BF1045754F

Q37786633-090A258A-EDB1-4C4D-A529-AF1409048691

Q37786633-14715B37-EC07-4C61-BC05-3152CA8140A4

Q37786633-1670F419-AB12-4C7C-B933-01DFCA6001AD

Q37786633-18F6447D-7F48-419E-A8A2-AD7B5AD204A6

P304

Q37786633-05A9E075-560A-49D6-8941-93D85FEA9BA1

P31

Q37786633-5D493679-D9DD-47BD-846C-AC7E2538F126

P356

Q37786633-1A1749D1-2603-4B10-972B-70F23EC50648

P433

Q37786633-39C93C24-BA1E-48B2-A85B-CF60E9197290

P478

Q37786633-E56D66F1-8670-4999-99EB-D329897F3EAA

P50

Q37786633-4E90282C-F01E-4F4A-8109-C217CC9C9A8C

P577

Q37786633-3D98FDEF-D6B6-4CCD-A0DC-67A000E10C92

P698

Q37786633-843BC26B-8A8E-4436-94E2-0FCDCF04A234

P921

Q37786633-BEC2D24B-8E47-4C9F-A787-7FBF3B3FC669

Q37786633-CA28E49D-3B05-4DBB-AC73-A66EF861228B

P356

P1433

Expert Review of Clinical Immunology

P1476

Innate antimicrobial immunity in inflammatory bowel diseases.

@en

P2093

Eduard F Stange

http://www.w3.org/2001/XMLSchema#string

Julia Beisner

http://www.w3.org/2001/XMLSchema#string

P2860

Beta-defensins: linking innate and adaptive immunity through dendritic and T cell CCR6

Inflammatory Bowel Disease

The contribution of NOD2 gene mutations to the risk and site of disease in inflammatory bowel disease

A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease

XBP1 links ER stress to intestinal inflammation and confers genetic risk for human inflammatory bowel disease

Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection

Antimicrobial peptides in the first line defence of human colon mucosa

Reduced Paneth cell alpha-defensins in ileal Crohn's disease

Human beta-defensin 2 is a salt-sensitive peptide antibiotic expressed in human lung

Human beta-defensin-1: an antimicrobial peptide of urogenital tissues

P304

809-818

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/ECI.10.56

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

P577

2010-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20828289

http://www.w3.org/2001/XMLSchema#string

P921

inflammatory bowel diseases